Papillomavirus Infections: all 505 studies
Page 5 of 6. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.
- A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.CompletedNCT02733068Phase 3
- Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)CompletedNCT02714114
- Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)Active, not recruitingNCT02653118
- Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® SpecimensCompletedNCT02634190
- Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)CompletedNCT02631863Phase 2
- Yallaferon in Chinese PopulationStatus unknownNCT02593968Phase 2
- Recurrent Respiratory Papillomatosis and Extraesophageal RefluxCompletedNCT02592902Not applicable
- HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3CompletedNCT02558803Not applicable
- Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory PapillomatosisStatus unknownNCT02555800Phase 2
- Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV VaccineCompletedNCT02546752Early Phase 1
- Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)CompletedNCT02535104Phase 1/2
- An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among WomenCompletedNCT02464358Not applicable
- HPV Self-Test Intervention in Ohio AppalachiaCompletedNCT02460237Not applicable
- Phase II Evaluation of AHCC for the Eradication of HPV InfectionsCompletedNCT02405533Not applicable
- Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy ParticipantsWithdrawnNCT02382419Phase 2
- On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus InfectionCompletedNCT02376478
- CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health CentersCompletedNCT02355262
- Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine CervixCompletedNCT02346227Phase 3
- Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical NeoplasiaCompletedNCT02304770Phase 2
- A New Supplement for the Immune Response to HPV InfectionCompletedNCT02263378Not applicable
- The Epidemiologic Study of Human Papillomavirus Infection and Related DiseasesCompletedNCT02188004
- Community-Driven Cervical Cancer Prevention in Western KenyaCompletedNCT02124252Not applicable
- Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles CountyCompletedNCT02067507Not applicable
- An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101CompletedNCT02065973Phase 1
- Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
- ICI-VPH: Impact of HPV Immunisation Schedules Against HPVCompletedNCT02009800Phase 3
- 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in ChildrenStatus unknownNCT01995721Phase 3
- Genotypification and Predisposing Factors in Human Papilloma Virus InfectionCompletedNCT01924117Not applicable
- The Parents in Appalachia Receive Education Needed for Teen ProjectActive, not recruitingNCT01901770Not applicable
- Human Papillomavirus and PregnancyStatus unknownNCT01897129
- Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted ProcreationCompletedNCT01894425
- Recombinant Human Interferon a-2b Gel for HPV Gynecological InfectionsCompletedNCT01824992Phase 2/3
- HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective StudyCompletedNCT01792973
- HPV in AdolescentsCompletedNCT01788852
- Genital HPV Infections Before and After Renal TransplantationCompletedNCT01717443
- Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIVStatus unknownNCT01709448
- Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) VaccineCompletedNCT01702337
- Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® SystemCompletedNCT01694875
- AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix InfectionsStatus unknownNCT01654822Phase 2
- Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer PreventionCompletedNCT01588301Early Phase 1
- Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) InfectionCompletedNCT01571141Phase 4
- Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)CompletedNCT01567813
- Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri LankaWithdrawnNCT01551537
- Home-Based or Clinic-Based Human Papillomavirus (HPV) ScreeningCompletedNCT01550783Not applicable
- Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote AreasCompletedNCT01539668
- Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital WartsCompletedNCT01532102Phase 1/2
- Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIVCompletedNCT01492842
- Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ SystemCompletedNCT01446198
- 3-year Immunogenicity Evaluation of Quadrivalent HPV Vaccine in ChinaStatus unknownNCT01427777
- e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma VirusesStatus unknownNCT01387997Not applicable
- APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test ResultsCompletedNCT01384370
- Effect of Vaccination in Patients With Recurrent Respiratory PapillomatosisCompletedNCT01375868Phase 3
- GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)TerminatedNCT01355003
- Randomized Comparison of Vaginal Self Sampling for Human Papillomavirus (HPV) Testing by Standard Versus Dry Vaginal SwabsStatus unknownNCT01316120Not applicable
- Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)Status unknownNCT01300689
- Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)CompletedNCT01295242
- Prevalence of Human Papillomavirus in Men Living in the Northern PlainsCompletedNCT01265212
- Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.CompletedNCT01226368
- An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of BahrainCompletedNCT01205412
- An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in EgyptCompletedNCT01158209
- A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot StudyStatus unknownNCT01133509Not applicable
- Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA TestCompletedNCT01104181Not applicable
- Self-collected Swabs for HPV Testing in 18-24 Year Old WomenCompletedNCT01101828
- Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)Status unknownNCT01095198Phase 2/3
- Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health CentersStatus unknownNCT01087164Not applicable
- Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191CompletedNCT01086709
- Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) VaccinationTerminatedNCT01082861Phase 4
- Propranolol Administration in Pediatric Patients With Recurrent Respiratory PapillomatosisWithdrawnNCT01058317Phase 2/3
- Immunogenicity of Off-Schedule Dosing of HPV VaccineCompletedNCT01030562
- Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in ChinaStatus unknownNCT01021904Phase 4
- Reactogenicity Study of Cervarix and Gardasil in UK Adolescent GirlsCompletedNCT00956553Phase 4
- Anal HPV Infection and Abnormal Cytology in HIV-infected WomenCompletedNCT00933140
- Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian MenCompletedNCT00932009
- Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical DysplasiaCompletedNCT00931190
- Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With MenCompletedNCT00919997
- CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical CellsActive, not recruitingNCT00892866Not applicable
- Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated ControlsActive, not recruitingNCT00867464
- Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian PopulationCompletedNCT00847340
- Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory PapillomatosisWithdrawnNCT00829608Early Phase 1
- Effectiveness of a Vaccination Program in the Community Ob/Gyn SettingCompletedNCT00828555
- The Human Papillomavirus (HPV) Transmission Pilot StudyCompletedNCT00823511
- Natural History of HPV Infection in Men: The HIM StudyCompletedNCT00786760
- HPV Infections in Older WomenCompletedNCT00743392
- Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)WithdrawnNCT00733122Phase 3
- A Study to Identify Markers in Blood and Tissue of HPV ClearanceCompletedNCT00711815
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3CompletedNCT00685412Phase 1
- Significance of the High-risk Hpv Viral LoadCompletedNCT00682812Not applicable
- A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)CompletedNCT00551187Phase 2
- Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRPCompletedNCT00550914
- Human Papillomavirus 6/11 in the Lower Airway of NeonatesCompletedNCT00549250
- Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)CompletedNCT00520598Phase 2
- Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus InfectionStatus unknownNCT00520078
- Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV InfectionCompletedNCT00508170
- Gardasil Vaccination as Therapy in Low Grade Cervical AbnormalitiesWithdrawnNCT00501189
- High-Risk HPV Infections in Women Aged 25 to 65CompletedNCT00461877
- Oral Human Papillomavirus Infection in HIV-infected MenStatus unknownNCT00421486
- Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive MenStatus unknownNCT00365729
- Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.TerminatedNCT00312286Phase 2
- Human Papillomavirus (HPV) Infection in PregnancyCompletedNCT00194311
- Screening for HIV-Associated Anal CancerCompletedNCT00188292